AUTL
Autolus Therapeutics plc
1.80$
+2.8%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 75.5% | 73.3% | 89.0% | 88.7% | 86.8% | 84.4% | 82.5% | 79.6% | 77.7% | 74.0% | 70.0% | 68.1% | |
| 63.2% | 63.8% | 84.3% | 82.8% | 79.4% | 29.0% | 12.8% | 17.2% | 13.0% | 17.7% | 24.8% | 34.8% | |
| 63.2% | 63.8% | 84.3% | 82.8% | 79.4% | 75.1% | 69.2% | 63.0% | 55.5% | 51.0% | 43.5% | 40.9% | |
| 10.3% | 0.3% | 3.4% | 4.3% | 0.1% | 6.2% | 1.9% | 10.9% | 13.8% | 12.9% | 16.4% | 9.0% | |
| 2.4% | -6.5% | – | -4.3% | – | 0.5% | 2.0% | 3.3% | 4.2% | 5.6% | 6.3% | 6.8% | |
| 23.2% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | 1.6% | 1.7% | 1.8% | 3.1% | 3.4% | 3.6% | 3.8% | |
| 55.5% | 70.3% | 35.4% | 38.2% | 42.4% | 45.4% | 50.3% | 51.9% | 59.9% | 69.8% | 79.4% | 84.8% | |
| 9.2% | 11.9% | 4.9% | 4.8% | 6.3% | 7.8% | 8.9% | 9.5% | 12.5% | 12.5% | 12.1% | 13.9% | |
| 1.4% | 1.3% | 0.5% | 0.5% | 0.4% | 0.4% | 0.4% | 0.5% | 0.7% | 2.5% | 0.6% | 1.2% | |
| 0.2% | 0.0% | 0.2% | 0.1% | 0.2% | 0.3% | 0.6% | 0.8% | 1.7% | 0.5% | 0.4% | 0.3% | |
| 44.5% | 29.7% | 64.6% | 61.8% | 57.6% | 54.6% | 49.7% | 48.1% | 40.1% | 30.2% | 20.6% | 15.2% | |
| -197.3% | -234.0% | -103.3% | -115.9% | -129.5% | -140.4% | -156.7% | -168.8% | -195.8% | -235.4% | -276.7% | -303.6% | |
| 42.8% | 46.4% | 24.6% | 31.2% | 32.2% | 34.0% | 35.7% | 36.9% | 40.2% | 45.2% | 50.5% | 54.0% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.